• Something wrong with this record ?

The anabolic role of the Warburg, Cori-cycle and Crabtree effects in health and disease

PB. Soeters, A. Shenkin, L. Sobotka, MR. Soeters, PW. de Leeuw, RR. Wolfe

. 2021 ; 40 (5) : 2988-2998. [pub] 20210217

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

In evolution, genes survived that could code for metabolic pathways, promoting long term survival during famines or fasting when suffering from trauma, disease or during physiological growth. This requires utilization of substrates, already present in some form in the body. Carbohydrate stores are limited and to survive long, their utilization is restricted to survival pathways, by inhibiting glucose oxidation and glycogen synthesis. This leads to insulin resistance and spares muscle protein, because being the main supplier of carbon for new glucose production. In these survival pathways, part of the glucose is degraded in glycolysis in peripheral (muscle) tissues to pyruvate and lactate (Warburg effect), which are partly reutilized for glucose formation in liver and kidney, completing the Cori-cycle. Another part of the glucose taken up by muscle contributes, together with muscle derived amino acids, to the production of substrates consisting of a complete amino acid mix but extra non-essential amino acids like glutamine, alanine, glycine and proline. These support cell proliferation, matrix deposition and redox regulation in tissues, specifically active in host response and during growth. In these tissues, also glucose is taken up delivering glycolytic intermediates, that branch off and act as building blocks and produce reducing equivalents. Lactate is also produced and released in the circulation, adding to the lactate released by muscle in the Cori-cycle and completing secondary glucose cycles. Increased fluxes through these cycles lead to modest hyperglycemia and hyperlactatemia in states of healthy growth and disease and are often misinterpreted as induced by hypoxia.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025776
003      
CZ-PrNML
005      
20211026133522.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.clnu.2021.02.012 $2 doi
035    __
$a (PubMed)33674148
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Soeters, Peter B $u Department of Surgery, Maastricht University Medical Centre, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands. Electronic address: pb.soeters@maastrichtuniversity.nl
245    14
$a The anabolic role of the Warburg, Cori-cycle and Crabtree effects in health and disease / $c PB. Soeters, A. Shenkin, L. Sobotka, MR. Soeters, PW. de Leeuw, RR. Wolfe
520    9_
$a In evolution, genes survived that could code for metabolic pathways, promoting long term survival during famines or fasting when suffering from trauma, disease or during physiological growth. This requires utilization of substrates, already present in some form in the body. Carbohydrate stores are limited and to survive long, their utilization is restricted to survival pathways, by inhibiting glucose oxidation and glycogen synthesis. This leads to insulin resistance and spares muscle protein, because being the main supplier of carbon for new glucose production. In these survival pathways, part of the glucose is degraded in glycolysis in peripheral (muscle) tissues to pyruvate and lactate (Warburg effect), which are partly reutilized for glucose formation in liver and kidney, completing the Cori-cycle. Another part of the glucose taken up by muscle contributes, together with muscle derived amino acids, to the production of substrates consisting of a complete amino acid mix but extra non-essential amino acids like glutamine, alanine, glycine and proline. These support cell proliferation, matrix deposition and redox regulation in tissues, specifically active in host response and during growth. In these tissues, also glucose is taken up delivering glycolytic intermediates, that branch off and act as building blocks and produce reducing equivalents. Lactate is also produced and released in the circulation, adding to the lactate released by muscle in the Cori-cycle and completing secondary glucose cycles. Increased fluxes through these cycles lead to modest hyperglycemia and hyperlactatemia in states of healthy growth and disease and are often misinterpreted as induced by hypoxia.
650    _2
$a zvířata $7 D000818
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a glykolýza $x fyziologie $7 D006019
650    _2
$a lidé $7 D006801
650    _2
$a ledviny $x metabolismus $7 D007668
650    _2
$a kyselina mléčná $x metabolismus $7 D019344
650    _2
$a játra $x metabolismus $7 D008099
650    _2
$a kosterní svaly $x metabolismus $7 D018482
650    _2
$a kyselina pyrohroznová $x metabolismus $7 D019289
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Shenkin, Alan $u Department of Clinical Chemistry, University of Liverpool, Liverpool, UK
700    1_
$a Sobotka, Lubos $u Third Department of Medicine, Medical Faculty Hospital Hradec Kralove, Charles University, Prague, Czech Republic
700    1_
$a Soeters, Maarten R $u Department of Endocrinology and Metabolism, Amsterdam University Medical Centres - Location AMC, University of Amsterdam, Amsterdam, the Netherlands
700    1_
$a de Leeuw, Peter W $u Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands
700    1_
$a Wolfe, Robert R $u Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA
773    0_
$w MED00001148 $t Clinical nutrition (Edinburgh, Scotland) $x 1532-1983 $g Roč. 40, č. 5 (2021), s. 2988-2998
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33674148 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133528 $b ABA008
999    __
$a ok $b bmc $g 1714699 $s 1146283
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 40 $c 5 $d 2988-2998 $e 20210217 $i 1532-1983 $m Clinical nutrition $n Clin Nutr $x MED00001148
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...